1.Effect of antianxiety drug augmentation in the neuroleptics treated schizophrenia patients.
Weon Jeong LIM ; Haing Won WOO
Journal of Korean Neuropsychiatric Association 1993;32(6):971-982
No abstract available.
Antipsychotic Agents*
;
Drug Synergism*
;
Humans
;
Schizophrenia*
3.Effect of Zingiber offiicinale and Aconitum cainichaeli before and after compatibility on contents of four gingerols.
Wenwen PENG ; Junsong LI ; Wen LI ; Baochang CAI
China Journal of Chinese Materia Medica 2012;37(14):2076-2078
OBJECTIVETo discuss the synergistic mechanism of compatible use of two medicinal herbs, Zingiber offiicinale and Aconitum cainichaeli, by determining single decoction of Z. offiicinale and four gingerols (6-gingerol, 8-gingerol, 6-shogaol, 10-gingerol) contained in compound decoction of Z. offiicinale and A. cainichaeli of different compatibility ratio using HPLC.
METHODKromasil-C18 column (4.6 mm x 250 mm, 5 microm) was adopted. The mobile phase was acetonitrile (B) and 0.1% aqueous acetic acid (A) for gradient elution (0-30 min, 40%-90% B; 30-35 min, 90%-40% B). The flow rate was 1.0 mL x min(-1). The detection wavelength was set at 275 nm. The column temperature was 30 degrees C.
RESULTThe four gingerols were in baseline separation, with a good linearity (r > 0.999), an average recovery of 100.9% -103.5% and RSD < 3.0%. Compared with the single decoction of Z. offiicinale, the content of gingerols in the compound decoction of Z. offiicinale and A. cainichaeli was on the rise and in direct proportion with the increase in the volume of A. cainichaeli.
CONCLUSIONThe synergistic mechanism of the compatibility of Z. offiicinale and A. cainichaeli can be proved with the increased release of gingerols from Z. offiicinale.
Aconitum ; Catechols ; analysis ; Drug Compounding ; Drug Synergism ; Fatty Alcohols ; analysis ; Ginger ; chemistry
4.Study on the compatibility optimization of categorized formulas of Chinese medicine based on support vector regression.
Xiufeng WANG ; Lei ZHANG ; Laicheng LUO ; Jianhong WANG
Journal of Biomedical Engineering 2012;29(6):1058-1061
Prediction on pharmacodynamic action of categorized formulas is presented with the theory of support vector regression (SVR) in this paper. A prediction model of pharmacodynamic action of categorized formulas based on SVR was set up in order to predict the law of the compatibility of the categorized formulas. Pharmacodynamic action of various categorized formulas could be predicted based on this model. It is very significient to optimize the compatibility of categorized formulas and clinical practice. This model was applied to the research of the law of compatibility in three categorized formulas for tonifying kidney yang which contains shenqi pill, yougui pill and yougui drink. As indicated in the model prediction, pharmacodynamic actions of several compatibilities of the categorized formulas are superior to that of the three original formulas for tonifying kidney yang.
Algorithms
;
Drug Synergism
;
Drug Therapy, Combination
;
Drugs, Chinese Herbal
;
administration & dosage
;
Models, Theoretical
;
Support Vector Machine
5.Stabilizers of horseradish peroxidase.
Xinhuan MAO ; Xiang LI ; Shanshan WANG ; Wenjing ZHANG ; Chengming ZENG
Chinese Journal of Biotechnology 2009;25(3):388-391
Keeping an enzyme in its native form with high catalytic activity is of great significance. In the present study, thermal stabilizers of horseradish peroxidase (HRP) were screened. The results indicated that thermal stability of HRP was enhanced by magnesium sulphate and gelatin. A synergic effect of magnesium sulphate and gelatin was observed. In the presence of the stabilizer, the enzymatic activity of HRP remained 89% after kept for 80 h at 50 degrees C and 57% for 90 days at room temperature. Thermal alterations of HRP structure in the absence and presence of the stabilizers were explored by using UV absorption spectra at 402 nm (Soret band), intrinsic fluorescence and 8-anilinonaphthalene-1-sulfonic acid (ANS) fluorescence. The results suggested that magnesium sulphate and gelatin attenuated the extent of unfolding of HRP and therefore the native enzyme structure was stabilized.
Drug Synergism
;
Enzyme Stability
;
drug effects
;
Gelatin
;
pharmacology
;
Horseradish Peroxidase
;
metabolism
;
Hot Temperature
;
Magnesium Sulfate
;
pharmacology
6.Enhancement effect of polychlorinated biphenyl on benzo (a) pyrene-induced DNA damage in HepG2 cells.
Ya-ling ZOU ; Rui-ping LAI ; Li-hong ZHOU ; Xiao-yan LI ; Wen-qing LU
Chinese Journal of Preventive Medicine 2006;40(2):97-100
OBJECTIVETo study the effect of polychlorinated biphenyl, Aroclor1254 on benzo (a) pyrene [B (a) P]-induced DNA damage in HepG2 cells.
METHODSHepG2 cells were pretreated with Aroclor1254 (11.5, 23 and 46 micromol/L) for 24 hours and then exposed to B (a) P (50 micromol/L). DMSO (10 ml/L) was used as solvent control. Single cell gel electrophoresis (SCGE) and high-performance liquid chromatography-electrochemical detection (HPLC-EC) assays were applied to detect DNA single-strand breaks and 8-hydroxy-2'-deoxyguanosine (8-OHdG) in HepG2 cells, respectively.
RESULTSAverage Oliver tail moment (OTM) and 8-OHdG level in HepG2 cells were significantly increased in B (a) P treated group (1.66 +/- 0.21), (23.31 +/- 6.02) 8-OHdG/10(6)dG than that in solvent control (0.79 +/- 0.15), (12.31 +/- 3.24) 8-OHdG/10(6)dG, respectively. In Aroclor 1254 treated group (11.5, 23.0, 46.0 micromol/L), average OTM were 0.88 +/- 0.20, 1.01 +/- 0.15 and 1.10 +/- 0.16, and 8-OHdG levels were (19.57 +/- 7.57), (22.80 +/- 9.16) and (31.74 +/- 9.25) 8-OHdG/10(6)dG, respectively. A concentration of 46 micromol/L Aroclor1254 caused a significant increase of 8-OHdG level as compared with the solvent control. After pretreatment of HepG2 cells with Aroclor1254 (11.5, 23.0 and 46.0 micromol/L), B (a) P induced more DNA strand breaks (OTM: 2.14 +/- 0.22, 2.43 +/- 0.32 and 2.71 +/- 0.31) and 8-OHdG [(32.50 +/- 3.81), (49.23 +/- 16.66) and (60.36 +/- 18.04) 8-OHdG/10(6)dG] in HepG2 cells than B (a) P alone.
CONCLUSIONAroclor1254 might enhance B (a) P-induced DNA damage in HepG2 cells, which should imply a synergistic effect of Aroclor1254 on the genotoxicity of B (a) P.
Benzo(a)pyrene ; toxicity ; Cell Line, Tumor ; DNA Damage ; drug effects ; Drug Synergism ; Humans ; Polychlorinated Biphenyls ; toxicity
7.Synergic effects of synthesis arecoline in combination with snail-killing drugs niclosamide.
Shu-jun XU ; Yi-jiao CHEN ; Xing-guo ZHOU ; Gui-ling LI
Chinese Journal of Preventive Medicine 2006;40(4):253-256
OBJECTIVETo prove that synthetic Are combination with snail-killing drug Nic can increase the effects of snail-killing remarkably.
METHODSIn indoor immersing experimentation, the experiments were divided into 4 groups, 30 snails in each group, to observe the rate of opening operculum, the rate of climbing adhesion and the rate of death at 3, 6 and 24 hours respectively. In field experimentation, we intermixed 0.1 mg/L Are with 0.2 mg/L Nic as sample as contrasted with 2 mg/L Nic and non-drug group. Immersing method (we chose three slots each size were 10 m x 2 m x 1 m.) and insufflation method (we chose three patch of bottomlands each area were 10 m x 5 m.) were used to kill snails separately and the death rate of fish, at the same time was observed.
RESULTSIn the room, as we added 0.1 mg/L Are to the solution of 0.1 mg/L and 0.2 mg/L Nic separately, the opening operculum rate for 6 hours was increased from 20% and 12% to 100% and 95%, the climbing adhesion rate for 6 hours decreased from 17% and 53% to 3% and 5%, the death rate for 24 hours increased from 25% and 40% to 90% and 100%. In the field, the snails death rate in sample group and in contrastive group applied with immersing method and insufflation method for 72 hours were 95.9%, 93.3% and 100%, 95.8%; only one small fish (2 cm long) died in sample group, and all fishes died in Nic group, and all fish were alive in non-drug group.
CONCLUSIONIt proved that synthetic Are combination with snail-killing drug Nic might decrease Nic dosage and toxicity and increase the effects of snail-killing.
Animals ; Arecoline ; pharmacology ; Drug Synergism ; Molluscacides ; pharmacology ; Niclosamide ; pharmacology ; Snails ; drug effects
8.Advance in studies on antibacterial effect of flavonoids.
Ting-Huo YOU ; Fan LIU ; Lu WEN ; Yu-Xiao ZOU ; Sen-Tai LIAO ; Geng-Sheng XIAO
China Journal of Chinese Materia Medica 2013;38(21):3645-3650
As antibiotic drug resistance has become one of the most serious threats to global public health, there is a pressing need to look for new effective therapeutic drugs. Flavonoids are a large class of chemicals widely exist in plants, and have such effects as direct antibiotics, synergistic antibiotics and inhibition of bacterial activity. In this article, we made a summary for the advance in studies on the antibacterial effects of flavonoids and their mechanism.
Animals
;
Anti-Bacterial Agents
;
chemistry
;
pharmacology
;
Bacteria
;
drug effects
;
Drug Synergism
;
Flavonoids
;
chemistry
;
pharmacology
;
Humans
9.Research progress of the natural small molecular products synergistically with antifungal agents to inhibit drug-resistant fungi.
Shan-Lun TAN ; Da-Zhi ZHANG ; Yuan-Ying JIANG
Acta Pharmaceutica Sinica 2014;49(8):1097-1104
The incidence of systemic fungal infections have increased dramatically, moreover, drug resistance including either primary (intrinsic) or secondary (acquired) resistance, becomes one of the main reasons accounting for the failure of treating invasive fungal infections in the past decades. Nowadays, clinically available antifungal drugs are limited and their combination in antifungal therapy was not effective. It is expected to be a new strategy to synergistically sensitize antifungal drugs against drug-resistant fungi by using new small molecules. Based on the study in our research group and the reported work of others, we reviewed the research of the natural products which have synergistic effect with the antifungal agents against drug-resistant fungi. This review focused on the resource, structure, pharmacological activity, and action mechanism of the compounds, as well as somewhat in common, and would provide theoretical base for seeking new drug against drug-resistance fungi.
Antifungal Agents
;
chemistry
;
pharmacology
;
Biological Products
;
chemistry
;
pharmacology
;
Drug Synergism
;
Fungi
;
drug effects
10.Combination & Augmentation Strategies in the Treatment of Depressive Disorder.
Journal of the Korean Society of Biological Psychiatry 2000;7(2):131-139
Even the pharmacotherapy is more effective than placebo for the treatment of depression, the outcome of pharmacoltherapy remains unsatisfactory for many patients. Apart from side effects, there are two major limitations of antidepressant therapy. One is the delayed onset of improvement and another is partial response. In order to address these clinical dilemmas, many psychiatrists more commonly employ add-on therapy. In past, the practice of using multiple drugs to enhance treatment response was called polypharamcy, and was disparaged as poor clinical practice. However, with improved understanding of how drugs affects the central nervous system and increased communication in journals and on computer networks about the relative merits of specific combinations, the scientific basis for the combining drugs is being defined. Indeed, the use of multiple medications as a stratege to enhance response has become both acceptable and widespread now a days. It is now referred to more positively as add-on therapy, co-medication, combination therapy, or drug augmentation. Thus, as the methods of practical strategies for treatment of depression, switching classes antidepressant drugs, combiantion therapy, augmentation strategies and brief treatment algorithm will be presented with items of considerations. However, when combination of drugs being tried, knowledges about the actin of mechanism, pharamcokinetics, and pharmacodynamics are essential to cope with the possible adversive reactions and to get the appropriate responses for the treatment of depressive symptoms.
Actins
;
Antidepressive Agents
;
Central Nervous System
;
Depression
;
Depressive Disorder*
;
Drug Synergism
;
Drug Therapy
;
Humans
;
Psychiatry